Dare Bioscience, Inc. (DARE) Total liabilities 2013–2025
Dare Bioscience, Inc. (DARE) total liabilities at each fiscal year-end, per SEC filings.
$29.6MFY2025 · since FY2013: $101.1M → $29.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $29.6M | +5.4% |
| FY2024 | $28.1M | +6.8% |
| FY2023 | $26.3M | -19.5% |
| FY2022 | $32.7M | +91.8% |
| FY2021 | $17.1M | — |
| FY2016 | $755,235 | — |
| FY2014 | $8.1M | -92.0% |
| FY2013 | $101.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice